Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
- 2016 -
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
August 2016 - 105 products
CI
Selomida Haut
7.5 g
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents
Schwabe Pharma AG
D
FB
G
IP
CI
Oxycodon-Naloxon-Mepha 5
mg/2.5 mg
30
9.13
26.35
10 %
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Oxycodon-Naloxon-Mepha 5
mg/2.5 mg
60
16.06
33.90
10 %
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Oxycodon-Naloxon-Mepha 10
mg/5 mg
30
13.94
31.60
10 %
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Oxycodon-Naloxon-Mepha 10
mg/5 mg
60
24.51
43.05
10 %
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Oxycodon-Naloxon-Mepha 20
mg/10 mg
30
23.51
42.00
10 %
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Oxycodon-Naloxon-Mepha 20
mg/10 mg
60
44.94
65.30
10 %
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Oxycodon-Naloxon-Mepha 40
mg/20 mg
30
43.53
63.75
10 %
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
● 
A+ / SL / SG
FB
G
IP
CI
Oxycodon-Naloxon-Mepha 40
mg/20 mg
60
84.08
107.85
10 %
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
● 
A+ / SL / SG
FB
G
L
IP
CI
Pramipexol ER Sandoz
0.375 mg
10
4.53
14.15
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Sandoz 0.75 mg
10
8.38
25.55
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Sandoz 0.75 mg
30
23.39
41.85
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Sandoz 1.5 mg
30
46.78
67.30
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Sandoz 3 mg
30
93.57
118.20
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Sandoz 4.5 mg
30
140.36
169.05
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol-Mepha ER 0.375 mg
10
4.53
14.15
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol-Mepha ER 0.75 mg
10
8.38
25.55
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol-Mepha ER 0.75 mg
30
23.39
41.85
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol-Mepha ER 1.5 mg
30
46.78
67.30
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol-Mepha ER 3 mg
30
93.56
118.15
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol-Mepha ER 4.5 mg
30
140.34
169.05
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Candesartan Spirig HC 4 mg
10
2.14
11.55
10 %
Tablets: Candesartanum Cilexetilum 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Candesartan Spirig HC 8 mg
30
7.23
17.10
10 %
Tablets: Candesartanum Cilexetilum 8 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Candesartan Spirig HC 8 mg
100
22.60
41.00
10 %
Tablets: Candesartanum Cilexetilum 8 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Candesartan Spirig HC 16 mg
30
8.73
25.90
10 %
Tablets: Candesartanum Cilexetilum 16 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Candesartan Spirig HC 16 mg
100
29.38
48.35
10 %
Tablets: Candesartanum Cilexetilum 16 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Candesartan Spirig HC 32 mg
30
13.23
30.80
10 %
Tablets: Candesartanum Cilexetilum 32 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Candesartan Spirig HC 32 mg
100
41.53
61.55
10 %
Tablets: Candesartanum Cilexetilum 32 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Acarizax
30
77.30
100.50
10 %
ALK-Abelló AG
A / SL
FB
G
L
IP
CI
Acarizax
90
231.92
268.65
10 %
ALK-Abelló AG
A / SL
FB
G
L
IP
PP
Idelvion 250 IU
250 IE
529.27
584.05
10 %
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
PP
Idelvion 500 IU
500 IE
1058.53
1127.10
10 %
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
PP
Idelvion 1000 IU
1000 IE
2117.06
2213.15
10 %
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
PP
Idelvion 2000 IU
2000 IE
4234.12
4385.25
10 %
CSL Behring Lengnau AG
B / SL
FB
G
IP
CI
Mezavant, 1,2 g
magensaftresistente
Retardtabletten
60
47.32
67.90
10 %
Mesalazinum 1.2 g
Takeda Pharma AG
B / SL
FB
G
L
IP
PP
Idelvion 3500 IU
3500 IE
7409.71
7643.40
10 %
Lyophilisate and solvent: Albutrepenonacogum Alfa 3500 UI
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
CI
Adenuric 80 mg
14
12.88
30.40
10 %
Coated tablets: Febuxostatum 80 mg
A. Menarini GmbH
B / SL
FB
G
L
IP
CI
Adenuric 80 mg
28
25.43
44.05
10 %
Coated tablets: Febuxostatum 80 mg
A. Menarini GmbH
B / SL
FB
G
L
IP
CI
Adenuric 80 mg
98
82.57
106.20
10 %
Coated tablets: Febuxostatum 80 mg
A. Menarini GmbH
B / SL
FB
G
L
IP
CI
PP
Uptravi 200 mcg
60
4448.37
4854.30
10 %
Coated tablets: Selexipagum
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
L
IP
CI
PP
Uptravi 200 mcg
140
9029.51
9572.10
10 %
Coated tablets: Selexipagum
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
L
IP
CI
PP
Uptravi 400 mcg
60
4448.37
4854.30
10 %
Coated tablets: Selexipagum
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
L
IP
CI
PP
Uptravi 600 mcg
60
4448.37
4854.30
10 %
Coated tablets: Selexipagum
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
L
IP
CI
PP
Uptravi 800 mcg
60
4448.37
4854.30
10 %
Coated tablets: Selexipagum
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
L
IP
CI
PP
Uptravi 1000 mcg
60
4448.37
4854.30
10 %
Coated tablets: Selexipagum 1 mg
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
L
IP
CI
PP
Uptravi 1200 mcg
60
4448.37
4854.30
10 %
Coated tablets: Selexipagum 1.2 mg
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
L
IP
CI
PP
Uptravi 1400 mcg
60
4448.37
4854.30
10 %
Coated tablets: Selexipagum 1.4 mg
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
L
IP
CI
PP
Uptravi 1600 mcg
60
4448.37
4854.30
10 %
Coated tablets: Selexipagum 1.6 mg
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
IP
CI
Nevanac 3 mg / ml
3 ml
12.73
30.25
10 %
Augentropfensuspension: Nepafenacum 3 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Kovaltry 500 I.E.
363.97
414.45
10 %
Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 500 UI
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Kovaltry 1000 I.E.
727.49
787.45
10 %
Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 1000 UI
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Kovaltry 2000 I.E.
1451.35
1530.15
10 %
Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 2000 UI
Bayer (Schweiz) AG
B / SL
FB
G
IP
ChloraPrep coloré,
solution pour application
cutanée avec 3.0 ml
applicateur
3 ml
PR
PR
k.A.
2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep coloré,
solution pour application
cutanée avec 10.5 ml
applicateur
10.5 ml
PR
PR
k.A.
2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep coloré,
solution pour application
cutanée avec 26 ml
applicateur
26 ml
PR
PR
k.A.
2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep coloré,
solution pour application
cutanée avec 3.0 ml
applicateur
25 x 3 ml
PR
PR
k.A.
2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep coloré,
solution pour application
cutanée avec 10.5 ml
applicateur
25 x 10.5 ml
PR
PR
k.A.
2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
CI
PP
Strensiq 40 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 100 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 100 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 100 mg/ml
PR
PR
k.A.
Injection solution: Asfotasum Alfa 100 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 100 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 100 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 100 mg/ml
12
PR
PR
k.A.
Injection solution: Asfotasum Alfa 100 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
Xylo-Mepha Plus
10 ml
PR
PR
k.A.
Nasal spray: 2 Active Agents
Mepha Pharma AG
D
FB
G
IP
CI
Ph
CM
Traumalix dolo patch
5
PR
PR
k.A.
Patch: Capsici Extractum Ethanolicum Liquidum 86.4 mg
Drossapharm AG
D
FB
G
IP
CI
Ph
CM
Traumalix dolo patch
10
PR
PR
k.A.
Patch: Capsici Extractum Ethanolicum Liquidum 86.4 mg
Drossapharm AG
D
FB
G
IP
Oxycodon-Naloxon-Mepha 30
mg/15 mg
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
A+
FB
G
IP
Oxycodon-Naloxon-Mepha 30
mg/15 mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Mepha Pharma AG
A+
FB
G
IP
CI
Candesartan Spirig HC 4 mg
7
1.50
5.80
k.A.
Tablets: Candesartanum Cilexetilum 4 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Candesartan Spirig HC 8 mg
28
6.75
15.95
k.A.
Tablets: Candesartanum Cilexetilum 8 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Candesartan Spirig HC 8 mg
98
22.15
41.85
k.A.
Tablets: Candesartanum Cilexetilum 8 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Candesartan Spirig HC 16 mg
28
8.15
17.55
k.A.
Tablets: Candesartanum Cilexetilum 16 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Candesartan Spirig HC 16 mg
98
28.80
49.45
k.A.
Tablets: Candesartanum Cilexetilum 16 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Candesartan Spirig HC 32 mg
28
12.35
26.50
k.A.
Tablets: Candesartanum Cilexetilum 32 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Candesartan Spirig HC 32 mg
98
40.70
63.10
k.A.
Tablets: Candesartanum Cilexetilum 32 mg
Spirig HealthCare AG
B
FB
G
CI
Selomida Haut
30 x 7.5 g
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents
Schwabe Pharma AG
D
FB
G
CI
H
Selomida Muskeln
12 x 7.5 g
PR
PR
k.A.
Pulvermischung: 5 Active Agents
Omida AG
D
FB
G
CI
H
Selomida Muskeln
30 x 7.5 g
PR
PR
k.A.
Pulvermischung: 5 Active Agents
Omida AG
D
FB
G
CI
Selomida Verdauung
12 x 7.5 g
PR
PR
k.A.
Pulvermischung: 6 Active Agents
Schwabe Pharma AG
D
FB
G
CI
Selomida Verdauung
30 x 7.5 g
PR
PR
k.A.
Pulvermischung: 6 Active Agents
Schwabe Pharma AG
D
FB
G
CI
H
Heidak Nervosität und
Überlastung
30 ml
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: 6 Active Agents
Heidak AG
D
FB
G
CI
H
Heidak Schlafstörungen
30 ml
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: 6 Active Agents
Heidak AG
D
FB
G
IP
ChloraPrep incolore
1.5 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep incolore
3 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep incolore
10.5 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep incolore
26 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep incolore
20 x 1.5 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep incolore
25 x 1.5 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep incolore
60 x 1 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep incolore
25 x 3 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
IP
ChloraPrep incolore
25 x 10.5 ml
PR
PR
k.A.
solution pour application cutanée avec applicateur: 2 Active Agents
BD Switzerland Sàrl
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home